Madeline
Analyst
UBS
Equibles does not estimate personal net worth.
About Madeline
Madeline is recorded as Analyst at UBS. Madeline has spoken on 2 earnings calls across 2 companies, most recently for Scholar Rock Holding Corp on August 6, 2026. Those appearances were for Scholar Rock Holding Corp (SRRK) and Revolution Medicines, Inc. (RVMD). The companies whose calls Madeline spoke on are classified in the Healthcare sector.
Madeline on recent calls
“We were just wondering, do you have any color or any feedback from the FDA on that later than expected reclassification of the Catalan site, given the decision was sort of expected by the end of July?”
“Just wanted to get any updated commentary around, obviously, there is some precedent in oncology to get accelerated approval in the first line based on similar data to what you have, along with the full approval that you're expecting for the second-line PDAC indications.”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current